Jean Bourhis

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


240 publications

Sous presse | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ...
 
Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial.
Burtness B., Haddad R., Dinis J., Trigo J., Yokota T., de Souza Viana L., Romanov I., Vermorken J., Bourhis J., Tahara M. et al. JAMA oncology. Peer-reviewed.
 
Clinical translation of FLASH radiotherapy: Why and how?
Bourhis J., Montay-Gruel P., Gonçalves Jorge P., Bailat C., Petit B., Ollivier J., Jeanneret-Sozzi W., Ozsahin M., Bochud F., Moeckli R. et al., 2019/10. Radiotherapy and oncology, 139 pp. 11-17. Peer-reviewed.
 
Dosimetric and preparation procedures for irradiating biological models with pulsed electron beam at ultra-high dose-rate.
Jorge P.G., Jaccard M., Petersson K., Gondré M., Durán M.T., Desorgher L., Germond J.F., Liger P., Vozenin M.C., Bourhis J. et al., 2019/10. Radiotherapy and oncology, 139 pp. 34-39. Peer-reviewed.
 
Treatment of a first patient with FLASH-radiotherapy.
Bourhis J., Sozzi W.J., Jorge P.G., Gaide O., Bailat C., Duclos F., Patin D., Ozsahin M., Bochud F., Germond J.F. et al., 2019/10. Radiotherapy and oncology, 139 pp. 18-22. Peer-reviewed.
 
Protonthérapie des carcinomes épidermoïdes des voies aérodigestives supérieures : de la physique à la clinique [Proton therapy for head and neck squamous cell carcinomas: From physics to clinic]
Beddok A., Vela A., Calugaru V., Tessonnier T., Kubes J., Dutheil P., Gérard A., Vidal M., Goudjil F., Florescu C. et al., 2019/09. Cancer radiotherapie, 23 (5) pp. 439-448. Peer-reviewed.
 
Correction to: Neoadjuvant chemoradiotherapy delivered with helical tomotherapy under daily image guidance for rectal cancer patients: efficacy and safety in a large, multi-institutional series.
De Bari B., Franzetti-Pellanda A., Saidi A., Biggiogero M., Hahnloser D., Montemurro M., Bourhis J., Zeverino M., Ozsahin M., 2019/08. Journal of cancer research and clinical oncology, 145 (8) p. 2167. Peer-reviewed.
 
Role of chemotherapy in 5000 patients with head and neck cancer treated by curative surgery: A subgroup analysis of the meta-analysis of chemotherapy in head and neck cancer.
Dauzier E., Lacas B., Blanchard P., Le Q.T., Simon C., Wolf G., Janot F., Horiuchi M., Tobias J.S., Moon J. et al., 2019/08. Oral oncology, 95 pp. 106-114. Peer-reviewed.
 
Isodose 20 Gy found as a threshold dose for radiation recall dermatitis.
Scher N., Vozenin M.C., Bouchaab H., Ozsahin M., Bourhis J., 2019/07. Clinical and translational radiation oncology, 17 pp. 14-16. Peer-reviewed.
 
Pravastatin Reverses Established Radiation-Induced Cutaneous and Subcutaneous Fibrosis in Patients With Head and Neck Cancer: Results of the Biology-Driven Phase 2 Clinical Trial Pravacur.
Bourgier C., Auperin A., Rivera S., Boisselier P., Petit B., Lang P., Lassau N., Taourel P., Tetreau R., Azria D. et al., 2019/06/01. International journal of radiation oncology, biology, physics, 104 (2) pp. 365-373. Peer-reviewed.
 
Long-term neurocognitive benefits of FLASH radiotherapy driven by reduced reactive oxygen species.
Montay-Gruel P., Acharya M.M., Petersson K., Alikhani L., Yakkala C., Allen B.D., Ollivier J., Petit B., Jorge P.G., Syage A.R. et al., 2019/05/28. Proceedings of the National Academy of Sciences of the United States of America, 116 (22) pp. 10943-10951. Peer-reviewed.
 
Prise en charge des tachycardies ventriculaires réfractaires par radiothérapie stéréotaxique [Management of refractory ventricular tachycardia using stereotactic body radiotherapy]
Jumeau R., Bourhis J., Ozsahin M., Vallet V., Zeverino M., Moeckli R., Kinj R., Vozenin M.C., Schwitter J., Herrera-Siklody C. et al., 2019/05/22. Revue medicale suisse, 15 (652) pp. 1082-1086. Peer-reviewed.
 
In air and in vivo measurement of the leaf open time in tomotherapy using the on-board detector pulse-by-pulse data.
Schopfer M., Bochud F.O., Bourhis J., Moeckli R., 2019/05. Medical physics, 46 (5) pp. 1963-1971. Peer-reviewed.
 
Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 Update.
Biau J., Lapeyre M., Troussier I., Budach W., Giralt J., Grau C., Kazmierska J., Langendijk J.A., Ozsahin M., O'Sullivan B. et al., 2019/05. Radiotherapy and oncology, 134 pp. 1-9. Peer-reviewed.
 
Neoadjuvant chemoradiotherapy delivered with helical tomotherapy under daily image guidance for rectal cancer patients: efficacy and safety in a large, multi-institutional series.
De Bari B., Franzetti-Pellanda A., Saidi A., Biggiogero M., Hahnloser D., Montemurro M., Bourhis J., Zeverino M., Ozsahin M., 2019/04. Journal of cancer research and clinical oncology, 145 (4) pp. 1075-1084. Peer-reviewed.
 
PET-based prognostic survival model after radiotherapy for head and neck cancer.
Castelli J., Depeursinge A., Devillers A., Campillo-Gimenez B., Dicente Y., Prior J.O., Chajon E., Jegoux F., Sire C., Acosta O. et al., 2019/03. European journal of nuclear medicine and molecular imaging, 46 (3) pp. 638-649. Peer-reviewed.
50-Gy Stereotactic Body Radiation Therapy to the Dominant Intraprostatic Nodule: Results From a Phase 1a/b Trial.
Herrera F.G., Valerio M., Berthold D., Tawadros T., Meuwly J.Y., Vallet V., Baumgartner P., Thierry A.C., De Bari B., Jichlinski P. et al., 2019/02/01. International journal of radiation oncology, biology, physics, 103 (2) pp. 320-334. Peer-reviewed.
 
Chimioradiothérapie des cancers de l’œsophage : revue critique de la littérature [Chemoradiation for oesophageal cancer: A critical review of the literature]
Blais E., Vendrely V., Sargos P., Créhange G., Huguet F., Maingon P., Simon J.M., Bourdais R., Ozsahin M., Bourhis J. et al., 2019/02. Cancer radiotherapie, 23 (1) pp. 62-72. Peer-reviewed.
 
Practical clinical guidelines for contouring the trigeminal nerve (V) and its branches in head and neck cancers.
Biau J., Dunet V., Lapeyre M., Simon C., Ozsahin M., Grégoire V., Bourhis J., 2019/02. Radiotherapy and oncology, 131 pp. 192-201. Peer-reviewed.
 
Cisplatin Eligibility Issues and Alternative Regimens in Locoregionally Advanced Head and Neck Cancer: Recommendations for Clinical Practice.
Szturz P., Cristina V., Herrera Gómez R.G., Bourhis J., Simon C., Vermorken J.B., 2019. Frontiers in oncology, 9 p. 464. Peer-reviewed.
 
The Advantage of FLASH Radiotherapy Confirmed in Mini-pig and Cat-cancer Patients.
Vozenin M.C., De Fornel P., Petersson K., Favaudon V., Jaccard M., Germond J.F., Petit B., Burki M., Ferrand G., Patin D. et al., 2019/01/01. Clinical cancer research, 25 (1) pp. 35-42. Peer-reviewed.
 
Analysis of the treatment plan evaluation process in radiotherapy through eye tracking.
Kyroudi A., Petersson K., Ozsahin M., Bourhis J., Bochud F., Moeckli R., 2018/12. Zeitschrift fur medizinische Physik, 28 (4) pp. 318-324. Peer-reviewed.
 
Determination of the effective dose delivered by image guided radiotherapy in head & neck and breast treatments.
Conrad M., Bolard G., Nowak M., De Bari B., Jeanneret-Sozzi W., Bourhis J., Germond J.F., Bochud F., Moeckli R., 2018/12. Zeitschrift fur medizinische Physik, 28 (4) pp. 276-285. Peer-reviewed.
 
X-rays can trigger the FLASH effect: Ultra-high dose-rate synchrotron light source prevents normal brain injury after whole brain irradiation in mice.
Montay-Gruel P., Bouchet A., Jaccard M., Patin D., Serduc R., Aim W., Petersson K., Petit B., Bailat C., Bourhis J. et al., 2018/12. Radiotherapy and oncology, 129 (3) pp. 582-588. Peer-reviewed.
 
Adaptive radiotherapy for head and neck cancer.
Castelli J., Simon A., Lafond C., Perichon N., Rigaud B., Chajon E., De Bari B., Ozsahin M., Bourhis J., de Crevoisier R., 2018/10. Acta oncologica, 57 (10) pp. 1284-1292. Peer-reviewed.
 
Randomized trial comparing two methods of re-irradiation after salvage surgery in head and neck squamous cell carcinoma: Once daily split-course radiotherapy with concomitant chemotherapy or twice daily radiotherapy with cetuximab.
Tao Y., Faivre L., Laprie A., Boisselier P., Ferron C., Jung G.M., Racadot S., Gery B., Even C., Breuskin I. et al., 2018/09. Radiotherapy and oncology, 128 (3) pp. 467-471. Peer-reviewed.
 
Rescue procedure for an electrical storm using robotic non-invasive cardiac radio-ablation.
Jumeau R., Ozsahin M., Schwitter J., Vallet V., Duclos F., Zeverino M., Moeckli R., Pruvot E., Bourhis J., 2018/08. Radiotherapy and oncology, 128 (2) pp. 189-191. Peer-reviewed.
 
Response to Spartalis et al.
Jumeau R., Ozsahin M., Moeckli R., Pruvot E., Bourhis J., 2018/08. Radiotherapy and oncology, 128 (2) p. 388. Peer-reviewed.
 
A treatment planning comparison of contemporary photon-based radiation techniques for breast cancer
Zeverino Michele, Petersson Kristoffer, Kyroudi Archonteia, Jeanneret-Sozzi Wendy, Bourhis Jean, Bochud Francois, Moeckli Raphael, 2018/07. Physics and Imaging in Radiation Oncology, 7 pp. 32-38.
 
(<sup>18</sup>F)-FDG PET/CT parameters to predict survival and recurrence in patients with locally advanced cervical cancer treated with chemoradiotherapy.
Scher N., Castelli J., Depeursinge A., Bourhis J., Prior J.O., Herrera F.G., Ozsahin M., 2018/05. Cancer radiotherapie, 22 (3) pp. 229-235. Peer-reviewed.
 
Approach to oligometastatic disease in head and neck cancer, on behalf of the GORTEC.
Sun X.S., Michel C., Babin E., De Raucourt D., Péchery A., Gherga E., Géry B., Florescu C., Bourhis J., Thariat J., 2018/04. Future oncology, 14 (9) pp. 877-889. Peer-reviewed.
 
Modern intensity-modulated radiotherapy with image guidance allows low toxicity rates and good local control in chemoradiotherapy for anal cancer patients.
De Bari B., Lestrade L., Franzetti-Pellanda A., Jumeau R., Biggiogero M., Kountouri M., Matzinger O., Miralbell R., Bourhis J., Ozsahin M. et al., 2018/04. Journal of cancer research and clinical oncology, 144 (4) pp. 781-789. Peer-reviewed.
 
A randomized trial of induction docetaxel-cisplatin-5FU followed by concomitant cisplatin-RT versus concomitant cisplatin-RT in nasopharyngeal carcinoma (GORTEC 2006-02).
Frikha M., Auperin A., Tao Y., Elloumi F., Toumi N., Blanchard P., Lang P., Sun S., Racadot S., Thariat J. et al., 2018/03/01. Annals of oncology, 29 (3) pp. 731-736. Peer-reviewed.
 
High dose-per-pulse electron beam dosimetry: Commissioning of the Oriatron eRT6 prototype linear accelerator for preclinical use.
Jaccard M., Durán M.T., Petersson K., Germond J.F., Liger P., Vozenin M.C., Bourhis J., Bochud F., Bailat C., 2018/02. Medical physics, 45 (2) pp. 863-874. Peer-reviewed.
Cellular Composition and Contribution of Tertiary Lymphoid Structures to Tumor Immune Infiltration and Modulation by Radiation Therapy.
Boivin G., Kalambaden P., Faget J., Rusakiewicz S., Montay-Gruel P., Meylan E., Bourhis J., Lesec G., Vozenin M.C., 2018. Frontiers in oncology, 8 p. 256. Peer-reviewed.
 
Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines.
Grégoire V., Evans M., Le Q.T., Bourhis J., Budach V., Chen A., Eisbruch A., Feng M., Giralt J., Gupta T. et al., 2018/01. Radiotherapy and oncology, 126 (1) pp. 3-24. Peer-reviewed.
Hepatobiliary scintigraphy allows the evaluation of short-term functional toxicity of liver stereotactic body radiotherapy: Results of a pilot study.
De Bari B., Breuneval T., Zeverino M., Godin S., Deantonio L., Geldhof C., Bourhis J., Schaefer N., Moeckli R., Prior J. et al., 2018. PloS one, 13 (10) pp. e0204013. Peer-reviewed.
 
Improved Outcome by Adding Concurrent Chemotherapy to Cetuximab and Radiotherapy for Locally Advanced Head and Neck Carcinomas: Results of the GORTEC 2007-01 Phase III Randomized Trial.
Tao Y., Auperin A., Sire C., Martin L., Khoury C., Maingon P., Bardet E., Kaminsky M.C., Lapeyre M., Chatellier T. et al., 2018. Journal of clinical oncology, 36 ( 31) pp. 3084-3090. Peer-reviewed.
 
Induction Chemotherapy Followed by Cetuximab Radiotherapy Is Not Superior to Concurrent Chemoradiotherapy for Head and Neck Carcinomas: Results of the GORTEC 2007-02 Phase III Randomized Trial.
Geoffrois L., Martin L., De Raucourt D., Sun X.S., Tao Y., Maingon P., Buffet J., Pointreau Y., Sire C., Tuchais C. et al., 2018. Journal of clinical oncology, 36 (31) pp. 3077-3083. Peer-reviewed.
 
Multicenter Randomized Double-Blind, Placebo-Controlled Trial GORTEC (Groupe Oncologie Radiotherapie Tete et Cou) 2009-01 Evaluating the Effect of the Regenerating Agent on Radiodermatitis of Head and Neck Cancer Patients.
Tao Y., Auperin A., Sire C., Martin M., Saliou M.G., Bardet E., Sun X.S., Chatellier T., Morand C., Cornely A. et al., 2017/11/01. International journal of radiation oncology, biology, physics, 99 (3) pp. 590-595. Peer-reviewed.
 
Doses aux organes à risque en radiothérapie conformationnelle et en radiothérapie stéréotaxique : les poumons [Lung dose constraints for normo-fractionated radiotherapy and for stereotactic body radiation therapy]
Blais E., Pichon B., Mampuya A., Antoine M., Lagarde P., Kantor G., Breton-Callu C., Lefebvre C., Gerard M., Aamarcha A. et al., 2017/10. Cancer radiotherapie, 21 (6-7) pp. 584-596. Peer-reviewed.
 
Présentation de l’étude Gortec 2017-03 : radiothérapie en conditions stéréotaxiques postopératoire des cancers localisés de l’oropharynx et de la cavité buccale avec marges à risque (PHRC-K-16-164) [Description of the GORTEC 2017-03 study: Postoperative stereotactic radiotherapy for early stage oropharyngeal and oral cavity cancer with high risk margin (PHRC-K-16-164)]
Biau J., Miroir J., Millardet C., Saroul N., Pham-Dang N., Racadot S., Huguet F., Kwiatkowski F., Pereira B., Bourhis J. et al., 2017/10. Cancer radiotherapie, 21 (6-7) pp. 527-532. Peer-reviewed.
 
Irradiation in a flash: Unique sparing of memory in mice after whole brain irradiation with dose rates above 100Gy/s.
Montay-Gruel P., Petersson K., Jaccard M., Boivin G., Germond J.F., Petit B., Doenlen R., Favaudon V., Bochud F., Bailat C. et al., 2017/09. Radiotherapy and oncology, 124 (3) pp. 365-369. Peer-reviewed.
 
Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis.
Lacas B., Bourhis J., Overgaard J., Zhang Q., Grégoire V., Nankivell M., Zackrisson B., Szutkowski Z., Suwiński R., Poulsen M. et al., 2017/09. The Lancet. Oncology, 18 (9) pp. 1221-1237. Peer-reviewed.
 
Very accelerated radiotherapy or concurrent chemoradiotherapy for N3 head and neck squamous cell carcinoma: Pooled analysis of two GORTEC randomized trials.
Tao Y., Aupérin A., Graff P., Lapeyre M., Grégoire V., Maingon P., Geoffrois L., Verrelle P., Calais G., Gery B. et al., 2017/08. Oral oncology, 71 pp. 61-66. Peer-reviewed.
 
A clinical distance measure for evaluating treatment plan quality difference with Pareto fronts in radiotherapy
Petersson Kristoffer, Kyroudi Archonteia, Bourhis Jean, Ceberg Crister, Knöös Tommy, Bochud François, Moeckli Raphaël, 2017/07. Physics and Imaging in Radiation Oncology, 3 pp. 53-56.
 
Early-stage Favourable Anal Cancer: A Retrospective Analysis of Clinical Outcomes of a Moderately Low Dose Elective Nodal Intensity-modulated Radiotherapy Schedule.
Lestrade L., Zilli T., Kountouri M., Jumeau R., Matzinger O., Bourhis J., Miralbell R., Ozsahin M., De Bari B., 2017/07. Clinical oncology, 29 (7) pp. e105-e109. Peer-reviewed.
 
Metabolic Tumor Volume and Total Lesion Glycolysis in Oropharyngeal Cancer Treated With Definitive Radiotherapy: Which Threshold Is the Best Predictor of Local Control?
Castelli J., Depeursinge A., de Bari B., Devillers A., de Crevoisier R., Bourhis J., Prior J.O., 2017/06. Clinical nuclear medicine, 42 (6) pp. e281-e285. Peer-reviewed.
 
Minimizing adjuvant treatment after transoral robotic surgery through surgical margin revision and exclusion of radiographic extracapsular extension: A Prospective observational cohort study.
Morisod B., Venara-Vulpe I.I., Alzuphar S., Monnier Y., Bongiovanni M., Hagmann P., Bouchaab H., Bourhis J., Simon C., 2017/05. Head & neck, 39 (5) pp. 965-973. Peer-reviewed.
 
TAT-RasGAP317-326 Enhances Radiosensitivity of Human Carcinoma Cell Lines In Vitro and In Vivo through Promotion of Delayed Mitotic Cell Death.
Tsoutsou P., Annibaldi A., Viertl D., Ollivier J., Buchegger F., Vozenin M.C., Bourhis J., Widmann C., Matzinger O., 2017/05. Radiation research, 187 (5) pp. 562-569. Peer-reviewed.
 
A PET-based nomogram for oropharyngeal cancers.
Castelli J., Depeursinge A., Ndoh V., Prior J.O., Ozsahin M., Devillers A., Bouchaab H., Chajon E., de Crevoisier R., Scher N. et al., 2017/04. European journal of cancer, 75 pp. 222-230. Peer-reviewed.
 
Commissioning of the Leksell Gamma Knife(®) Icon™.
Zeverino M., Jaccard M., Patin D., Ryckx N., Marguet M., Tuleasca C., Schiappacasse L., Bourhis J., Levivier M., Bochud F.O. et al., 2017/04. Medical physics, 44 (2) pp. 355-363. Peer-reviewed.
 
High dose-per-pulse electron beam dosimetry: Usability and dose-rate independence of EBT3 Gafchromic films.
Jaccard M., Petersson K., Buchillier T., Germond J.F., Durán M.T., Vozenin M.C., Bourhis J., Bochud F.O., Bailat C., 2017/04. Medical physics, 44 (2) pp. 725-735. Peer-reviewed.
 
Les promesses du haut débit de dose en radiothérapie [Hopes of high dose-rate radiotherapy]
Fouillade C., Favaudon V., Vozenin M.C., Romeo P.H., Bourhis J., Verrelle P., Devauchelle P., Patriarca A., Heinrich S., Mazal A. et al., 2017/04. Bulletin du cancer, 104 (4) pp. 380-384. Peer-reviewed.
 
Prolonged Apnea Supported by High-Frequency Noninvasive Ventilation: A Pilot Study.
Ogna A., Bernasconi M., Belmondo B., Long O., Simons J., Peguret N., Heinzer R., Nicod L.P., Bourhis J., Lovis A., 2017/04/01. American journal of respiratory and critical care medicine, 195 (7) pp. 958-960. Peer-reviewed.
 
Sparing healthy lung by focusing the radiation beam flow onto the emphysematous regions in the treatment of lung cancer.
Jumeau R., Peguret N., de Bari B., Moeckli R., Soares-Rodrigues J.L., Durham A.D., Hojnowski S., Bourhis J., Ozsahin M., Beigelman-Aubry C., 2017/04. Journal of medical imaging and radiation oncology, 61 (2) pp. 252-257. Peer-reviewed.
 
Surrogate End Points for Overall Survival in Loco-Regionally Advanced Nasopharyngeal Carcinoma: An Individual Patient Data Meta-analysis.
Rotolo F., Pignon J.P., Bourhis J., Marguet S., Leclercq J., Tong Ng W., Ma J., Chan A.T., Huang P.Y., Zhu G. et al., 2017/04. Journal of the National Cancer Institute, 109 (4) pp. 1-9. Peer-reviewed.
 
High dose-per-pulse electron beam dosimetry - A model to correct for the ion recombination in the Advanced Markus ionization chamber.
Petersson K., Jaccard M., Germond J.F., Buchillier T., Bochud F., Bourhis J., Vozenin M.C., Bailat C., 2017/03. Medical physics, 44 (3) pp. 1157-1167. Peer-reviewed.
Implementation of TomoEDGE in the independent dose calculator CheckTomo.
Schopfer M., Thomas S.J., Tudor G.S., Bourhis J., Bochud F., Moeckli R., 2017/03. Journal of applied clinical medical physics, 18 (2) pp. 92-99. Peer-reviewed.
 
Can Segmentectomy Still Be Proposed As an Alternative to Lobectomy in 2016?
De Bari B., Durham A., Bourhis J., Ozsahin M., 2017/02/10. Journal of clinical oncology, 35 (5) pp. 573-574. Peer-reviewed.
 
What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis.
Ribassin-Majed L., Marguet S., Lee AWM, Ng W.T., Ma J., Chan ATC, Huang P.Y., Zhu G., Chua DTT, Chen Y. et al., 2017/02/10. Journal of clinical oncology, 35 (5) pp. 498-505. Peer-reviewed.
 
How could breast cancer molecular features contribute to locoregional treatment decision making?
Tsoutsou P.G., Vozenin M.C., Durham A.D., Bourhis J., 2017/02. Critical reviews in oncology/hematology, 110 pp. 43-48. Peer-reviewed.
 
Chest-MRI under pulsatile flow ventilation: A new promising technique.
Beigelman-Aubry C., Peguret N., Stuber M., Delacoste J., Belmondo B., Lovis A., Simons J., Long O., Grant K., Berchier G. et al., 2017. PloS one, 12 (6) pp. e0178807. Peer-reviewed.
Enhancement of IUdR Radiosensitization by Low-Energy Photons Results from Increased and Persistent DNA Damage.
Bayart E., Pouzoulet F., Calmels L., Dadoun J., Allot F., Plagnard J., Ravanat J.L., Bridier A., Denozière M., Bourhis J. et al., 2017. PloS one, 12 (1) pp. e0168395. Peer-reviewed.
 
Radiotherapy combination opportunities leveraging immunity for the next oncology practice.
Herrera F.G., Bourhis J., Coukos G., 2017/01. CA: a cancer journal for clinicians, 67 (1) pp. 65-85. Peer-reviewed.
Overview of the predictive value of quantitative 18 FDG PET in head and neck cancer treated with chemoradiotherapy.
Castelli J., De Bari B., Depeursinge A., Simon A., Devillers A., Roman Jimenez G., Prior J., Ozsahin M., de Crevoisier R., Bourhis J., 2016/12. Critical reviews in oncology/hematology, 108 pp. 40-51. Peer-reviewed.
Difference in performance between 3D and 4D CBCT for lung imaging: a dose and image quality analysis.
Thengumpallil S., Smith K., Monnin P., Bourhis J., Bochud F., Moeckli R., 2016/11/08. Journal of applied clinical medical physics, 17 (6) p. 6459. Peer-reviewed.
 
Role of functional imaging in treatment plan optimization of stereotactic body radiation therapy for liver cancer.
De Bari B., Jumeau R., Deantonio L., Adib S., Godin S., Zeverino M., Moeckli R., Bourhis J., Prior J.O., Ozsahin M., 2016/10/13. Tumori, 102 (5) pp. e21-e24. Peer-reviewed.
 
Discrepancies between selected Pareto optimal plans and final deliverable plans in radiotherapy multi-criteria optimization.
Kyroudi A., Petersson K., Ghandour S., Pachoud M., Matzinger O., Ozsahin M., Bourhis J., Bochud F., Moeckli R., 2016/08. Radiotherapy and oncology, 120 (2) pp. 346-348. Peer-reviewed.
 
Hypofractionated radiotherapy in pancreatic cancer: Lessons from the past in the era of stereotactic body radiation therapy.
De Bari B., Porta L., Mazzola R., Alongi F., Wagner A.D., Schäfer M., Bourhis J., Ozsahin M., 2016/07. Critical reviews in oncology/hematology, 103 pp. 49-61. Peer-reviewed.
 
Efficacy and safety of helical tomotherapy with daily image guidance in anal canal cancer patients.
De Bari B., Jumeau R., Bouchaab H., Vallet V., Matzinger O., Troussier I., Mirimanoff R.O., Wagner A.D., Hanhloser D., Bourhis J. et al., 2016/06. Acta oncologica (Stockholm, Sweden), 55 (6) pp. 767-773. Peer-reviewed.
 
Should we include SPECT lung perfusion in radiotherapy treatment plans of thoracic targets? Evidences from the literature.
De Bari B., Deantonio L., Bourhis J., Prior J.O., Ozsahin M., 2016/06. Critical reviews in oncology/hematology, 102 pp. 111-117. Peer-reviewed.
Optimization of re-irradiation using deformable registration: a case study
Jumeau Raphaël, Péguret Nicolas, Zulliger Cédric, Moeckli Raphaël, Bourhis Jean, Ozsahin Esat-Mahmut, 2016/05. BJR|case reports, 2 (2) p. 20150412.
 
Prise en charge des tumeurs cérébrales primaires: une approche multidisciplinaire [Multidisciplinar approach to the management of gliomas]
Moura B., Migliorini D., Bourhis J., Daniel R., Levivier M., Hottinger A.F., 2016/04/27. Revue medicale suisse, 12 (516) pp. 821-825.
[(18)F]FDG-PET/CT metabolic parameters as useful prognostic factors in cervical cancer patients treated with chemo-radiotherapy.
Herrera F.G., Breuneval T., Prior J.O., Bourhis J., Ozsahin M., 2016/03/16. Radiation oncology, 11 p. 43. Peer-reviewed.
Reduction of Respiratory Motion During PET/CT by Pulsatile-Flow Ventilation: A First Clinical Evaluation.
Prior J.O., Péguret N., Pomoni A., Pappon M., Zeverino M., Belmondo B., Lovis A., Ozsahin M., Vienne M., Bourhis J., 2016/03. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 57 (3) pp. 416-419. Peer-reviewed.
 
Apnea-like suppression of respiratory motion: First evaluation in radiotherapy.
Péguret N., Ozsahin M., Zeverino M., Belmondo B., Durham A.D., Lovis A., Simons J., Long O., Duclos F., Prior J. et al., 2016. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology, 118 (2) pp. 220-226. Peer-reviewed.
 
Can Stereotactic Body Radiotherapy Really Be Considered the Preferred Treatment in Large Hepatocellular Carcinoma?
De Bari B., Ozsahin M., Bize P., Boussaha T., Deplanque G., Wagner D., Bourhis J., Denys A., 2016. Journal of Clinical Oncology, 34 (23) pp. 2798-2799. Peer-reviewed.
 
Impact of respiratory-correlated CT sorting algorithms on the choice of margin definition for free-breathing lung radiotherapy treatments.
Thengumpallil S., Germond J.F., Bourhis J., Bochud F., Moeckli R., 2016. Radiotherapy and Oncology, 119 (3) pp. 438-443. Peer-reviewed.
 
Influence of Nucleoshuttling of the ATM Protein in the Healthy Tissues Response to Radiation Therapy: Toward a Molecular Classification of Human Radiosensitivity.
COPERNIC project investigators, Granzotto A., Granzotto A., Benadjaoud M.A., Vogin G., Devic C., Ferlazzo M.L., Bodgi L., Pereira S., Sonzogni L. et al., 2016. International Journal of Radiation Oncology, Biology, Physics, 94 (3) pp. 450-460. Peer-reviewed.
 
Reply to N.F. Saba and S.J. Wong.
Harrington K.J., Bourhis J., 2016. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 34 (17) pp. 2073-2074. Peer-reviewed.
 
Coronary stenosis risk analysis following Hodgkin lymphoma radiotherapy: A study based on patient specific artery segments dose calculation.
Moignier A., Broggio D., Derreumaux S., Beaudré A., Girinsky T., Paul J.F., Drubay D., Lefkopoulos D., Franck D., Aubert B. et al., 2015/12. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 117 (3) pp. 467-472.
 
A metastatic relapse associated with hippocampal dose sparing after whole-brain radiotherapy.
Cosinschi A., Coskun M., Negretti L., Matzinger O., Jeanneret-Sozzi W., Vallet V., Moeckli R., Mirimanoff R.O., Schiappacasse L., Ozsahin M. et al., 2015/11. Acta oncologica, 54 (10) pp. 1824-1826. Peer-reviewed.
 
Treatment deintensification and symptom burden in patients with human papillomavirus-associated head and neck cancer.
Ozsahin M., Bourhis J., 2015/11. Cancer, 121 (7) pp. 1147-1148. Peer-reviewed.
 
Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase II GORTEC study.
Guigay J., Fayette J., Dillies A.F., Sire C., Kerger J.N., Tennevet I., Machiels J.P., Zanetta S., Pointreau Y., Bozec Le Moal L. et al., 2015/09. Annals of oncology : official journal of the European Society for Medical Oncology, 26 (9) pp. 1941-1947.
 
Gamma Knife surgery versus Linac for brain metastases : which technique for which patient? Analysis of an historical cohort of 63 consecutive patients harbouring 130 lesions
Levivier M., Tuleasca C., Schiappacasse L., Gevaert T., Faouzi M., von Elm E., Steenbecke F., Engels B., de Ridder M., Bourhis J., 2015/06., 12-th International Stereotactic Radiosurgery Society Congress (ISRS), June 2015, Yokohama, Japan p. 42 dans Journal of Radiosurgery and SBRT.
 
Stereotactic body radiotherapy with helical TomoTherapy for medically inoperable early stage primary and second-primary non-small-cell lung neoplasm: 1-year outcome and toxicity analysis.
Casutt A., Bouchaab H., Beigelman-Aubry C., Bourhis J., Lovis A., Matzinger O., 2015/05. British Journal of Radiology, 88 (1049) p. 20140687. Peer-reviewed.
 
Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis.
Blanchard P., Lee A., Marguet S., Leclercq J., Ng W.T., Ma J., Chan A.T., Huang P.Y., Benhamou E., Zhu G. et al., 2015. Lancet. Oncology, 16 (6) pp. 645-655. Peer-reviewed.
 
CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines.
Brouwer C.L., Steenbakkers R.J., Bourhis J., Budach W., Grau C., Grégoire V., van Herk M., Lee A., Maingon P., Nutting C. et al., 2015. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology, 117 (1) pp. 83-90. Peer-reviewed.
 
Gamma Knife Surgery versus Linac for Brain Metastasis: Which Technique for Which Patient? Analysis of an Historical Cohort of 63 Consecutive Patients Harboring 130 Lesions
Levivier M., Tuleasca C., Schiappacasse L., Gevaert T., Faouzi M., Von Elm E., Steenbecke F., Engels B., de Ridder M., Bourhis J., 2015., Joint Annual Meeting 2015: Swiss Society of Neurosurgery and Swiss Society of Neuroradiology Together with IG-NOPPS, Lucerne, Switzerland, 10-11 September 2015 pp. 1-2 dans journal of Neurological Surgery Part A: Central European Neurosurgery.
 
Helical tomotherapy for the treatment of anal canal cancer: a dosimetric comparison with 3D conformal radiotherapy.
Ugurluer G., Ballerini G., Moeckli R., Matzinger O., Bourhis J., Ozsahin M., 2015. Tumori, 101 (3) pp. 268-272. Peer-reviewed.
 
Méta-analyses d'essais randomisés sur données individuelles dans le traitement des cancers ORL non métastatiques : principes, résultats, perspectives [Individual patient data meta-analyses of randomized trials for the treatment of non-metastatic head and neck squamous cell carcinomas: Principles, results and perspectives].
Blanchard P., Bourhis J., Lacas B., Le Teuff G., Michiels S., Pignon J.P., 2015. Cancer Radiothérapie, 19 (3) pp. 198-204. Peer-reviewed.
 
Postoperative Adjuvant Lapatinib and Concurrent Chemoradiotherapy Followed by Maintenance Lapatinib Monotherapy in High-Risk Patients With Resected Squamous Cell Carcinoma of the Head and Neck: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study.
Harrington K., Temam S., Mehanna H., D'Cruz A., Jain M., D'Onofrio I., Manikhas G., Horvath Z., Sun Y., Dietzsch S. et al., 2015. Journal of Clinical Oncology, 33 (35) pp. 4202-4209. Peer-reviewed.
 
Research Progress in Head and Neck Squamous Cell Carcinoma: Best Abstracts of ICHNO 2015.
Economopoulou P., Bourhis J., Psyrri A., 2015. American Society of Clinical Oncology Educational Book / Asco. American Society of Clinical Oncology. Meeting pp. e323-e328. Peer-reviewed.
 
The radiosensitizing activity of the SMAC-mimetic, Debio 1143, is TNFα-mediated in head and neck squamous cell carcinoma.
Matzinger O., Viertl D., Tsoutsou P., Kadi L., Rigotti S., Zanna C., Wiedemann N., Vozenin M.C., Vuagniaux G., Bourhis J., 2015. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology, 116 (3) pp. 495-503. Peer-reviewed.
 
Tumor-infiltrating lymphocytes in triple-negative breast cancer: a biomarker for use beyond prognosis?
Tsoutsou P.G., Bourhis J., Coukos G., 2015. Journal of Clinical Oncology, 33 (11) pp. 1297-1298. Peer-reviewed.
 
[(18)F]FDG-PET Standard Uptake Value as a Metabolic Predictor of Bone Marrow Response to Radiation: Impact on Acute and Late Hematological Toxicity in Cervical Cancer Patients Treated With Chemoradiation Therapy.
Elicin O., Callaway S., Prior J.O., Bourhis J., Ozsahin M., Herrera F.G., 2014. International Journal of Radiation Oncology, Biology, Physics, 90 (5) pp. 1099-1107. Peer-reviewed.
Afatinib versus placebo as adjuvant therapy after chemoradiation in a double-blind, phase III study (LUX-Head & Neck 2) in patients with primary unresected, clinically intermediate-to-high-risk head and neck cancer: study protocol for a randomized controlled trial.
Burtness B., Bourhis J.P., Vermorken J.B., Harrington K.J., Cohen E.E., 2014. Trials, 15 p. 469.
 
Cancer du sein: radiothérapie et signalisation oestrogénique [Breast cancer: radiotherapy and estrogen signaling].
Bourgier C., Lemanski C., Romieu G., Ozsahin M., Azria D., 2014. Bulletin du Cancer, 101 (7-8) pp. 714-717. Peer-reviewed.
 
Carcinomes épidermoïdes de l'hypopharynx et du larynx : prise en charge fondée sur les preuves Squamous cell carcinoma of the hypopharynx and larynx: evidence-based care.
Fayette J., Pointreau Y., Bourhis J., Lefebvre J.L., 2014. Bulletin du Cancer, 101 (5) pp. 438-444. Peer-reviewed.
 
Choline-PET in prostate cancer management: The point of view of the radiation oncologist.
De Bari B., Alongi F., Lestrade L., Giammarile F., 2014. Critical Reviews In Oncology/hematology, 91 (3) pp. 234-247. Peer-reviewed.
 
Concurrent use of cisplatin or cetuximab with definitive radiotherapy for locally advanced head and neck squamous cell carcinomas. Strahlentherapie in Kombination mit platinbasierter Chemotherapie oder Cetuximab zur Behandlung von lokal fortgeschrittenen Plattenepithelkarzinomen im Kopf-Hals-Bereich.
Levy A., Blanchard P., Bellefqih S., Brahimi N., Guigay J., Janot F., Temam S., Bourhis J., Deutsch E., Daly-Schveitzer N. et al., 2014. Strahlentherapie Und Onkologie, 190 (9) pp. 823-831. Peer-reviewed.
 
Critères de qualité en radiothérapie des cancers de la tête et du cou sous l'égide de l'Intergroupe ORL Quality criteria in radiotherapy for head and neck cancers under the aegis of Head and Neck Intergroup.
Tao Y., Vintonenko N., Garcia R., Marchesi V., Tomsej M., Bardet E., Bourhis J., 2014. Bulletin du Cancer, 101 (5) pp. 481-485.
 
External beam radiotherapy ± chemotherapy in the treatment of anal canal cancer: a single-institute long-term experience on 100 patients.
De Bari B., Buglione M., Maddalo M., Lestrade L., Spiazzi L., Vitali P., Barbera F., Magrini S.M., 2014. Cancer Investigation, 32 (6) pp. 248-255. Peer-reviewed.
 
Feasibility of radiotherapy or chemoradiotherapy after taxane-based induction chemotherapy for nonoperated locally advanced head and neck squamous cell carcinomas.
Levy A., Blanchard P., Bellefqih S., Brahimi N., Guigay J., Janot F., Temam S., Daly-Schveitzer N., Bourhis J., Tao Y., 2014. Anti-cancer Drugs, 25 (10) pp. 1220-1226. Peer-reviewed.
 
Four years with FALCON - an ESTRO educational project: achievements and perspectives.
Eriksen J.G., Salembier C., Rivera S., De Bari B., Berger D., Mantello G., Müller A.C., Martin A.N., Pasini D., Tanderup K. et al., 2014. Radiotherapy and Oncology, 112 (1) pp. 145-149. Peer-reviewed.
 
From radiobiology to technology: what is changing in radiotherapy for prostate cancer.
De Bari B., Fiorentino A., Arcangeli S., Franco P., D'Angelillo R.M., Alongi F., 2014. Expert Review of Anticancer Therapy, 14 (5) pp. 553-564. Peer-reviewed.
 
Improving safety in radiotherapy: The implementation of the Global Risk Analysis method.
Mazeron R., Aguini N., Rivin E., Baudré A., Bour M.S., Dumas I., Hubert F., Lopes S., Desroches A., Deutsch E. et al., 2014. Radiotherapy and Oncolog, 112 (2) pp. 205-11. Peer-reviewed.
 
Long-term Outcome and Late Side Effects in Endometrial Cancer Patients Treated with Surgery and Postoperative Radiation Therapy.
Herrera F.G., Cruz O.S., Achtari C., Bourhis J., Ozsahin M., 2014. Annals of Surgical Oncology, 21 (7) pp. 2390-2397.
 
Prise en charge des cancers du cavum (rhinopharynx) Nasopharyngeal cancers, an overview.
Jardel P., Thariat J., Blanchard P., Elloumi F., Toumi N., Bensadoun R.J., Frikha M., Daoud J., Bourhis J., 2014. Bulletin du Cancer, 101 (5) pp. 445-454.
 
Reply to D. Tural et al.
Blanchard P., Bourhis J., Pignon J.P., 2014. Journal of Clinical Oncology, 32 (3) pp. 259-260.
 
Squamous cell carcinoma of the larynx with subglottic extension: is larynx preservation possible?. Plattenepithelkarzinom des Larynx mit subglottischer Ausdehnung: ist ein Larynxerhalt möglich ?
Levy A., Blanchard P., Temam S., Maison M.M., Janot F., Mirghani H., Bidault F., Guigay J., Lusinchi A., Bourhis J. et al., 2014. Strahlentherapie Und Onkologie, 190 (7) pp. 654-660. Peer-reviewed.
 
The PEDRO (Pocketable Electronic Devices in Radiation Oncology) project: how clinical practice is changing among young radiation oncologists.
De Bari B., Franco P., Ciammella P., Peruzzo Cornetto A., Greto D., Fundoni C., Filippi A.R., Alongi F., AIRO Giovani (Italian Association of Radiation Oncology-Young Members Working Group), 2014. Tumori, 100 (6) pp. 236e-242e. Peer-reviewed.
 
The role of stereotactic ablative radiotherapy in oncological and non-oncological clinical settings: highlights from the 7th Meeting of AIRO - Young Members Working Group (AIRO Giovani).
Franco P., De Bari B., Ciammella P., Fiorentino A., Chiesa S., Amelio D., Pinzi V., Bonomo P., Vagge S., Fiore M. et al., 2014. Tumori, 100 (6) pp. 214e-229e. Peer-reviewed.
 
Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice.
Favaudon V., Caplier L., Monceau V., Pouzoulet F., Sayarath M., Fouillade C., Poupon M.F., Brito I., Hupé P., Bourhis J. et al., 2014. Science Translational Medicine, 6 (245) pp. 245ra93. Peer-reviewed.
 
Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer.
Lartigau E.F., Tresch E., Thariat J., Graff P., Coche-Dequeant B., Benezery K., Schiappacasse L., Degardin M., Bondiau P.Y., Peiffert D. et al., 2013/11. Radiotherapy and Oncology, 109 (2) pp. 281-285. Peer-reviewed.
 
Multimodal treatment and long-term outcome of patients with esthesioneuroblastoma.
Modesto A., Blanchard P., Tao Y.G., Rives M., Janot F., Serrano E., Benlyazid A., Guigay J., Ferrand F.R., Delord J.P. et al., 2013/08. Oral oncology, 49 (8) pp. 830-834. Peer-reviewed.
 
Curiethérapie des cancers des voies aérodigestives supérieures [Brachytherapy for head and neck cancers]
Lapeyre M., Coche-Dequéant B., Moreira J.F., Le Bourhis J., Peiffert D., 2013/04. Cancer radiotherapie, 17 (2) pp. 130-135. Peer-reviewed.
 
Nomograms predicting locoregional recurrence in the subtype era of breast cancer.
Tsoutsou P.G., Jeanneret Sozzi W., Matzinger O., Ozsahin M., 2013/02/10. Journal of clinical oncology, 31 (5) pp. 647-648. Peer-reviewed.
 
Adenosquamous carcinoma of the head and neck: report of 20 cases and review of the literature.
Schick U., Pusztaszeri M., Betz M., Ghadjar P., Demiroz C., Kaanders J.H., Ozsahin M., 2013. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 116 (3) pp. 313-320. Peer-reviewed.
 
Bio-radiation dermatitis: the need of a new grading: in regard to Bernier et al: Ann Oncol 2011; 22(10): 2191-2200.
Russi E.G., Bensadoun R.J., Merlano M.C., Bourhis J., Ricardi U., Giralt J., Pinto C., Budach W., Corvo R., Lacouture M.E. et al., 2013. Annals of Oncology, 24 (9) pp. 2463-2465.
 
Centre de la prostate: une approche multidisciplinaire pour une prise en charge globale du patient [Prostate cancer center: a multidisciplinary approach to accurately manage patients with prostate cancer]
Tawadros T., Burruni R., Herrera F., Codeluppi C., Zurkinden C., Meuwly J.Y., Lhermitte B., Berthold D., 2013. Revue Médicale Suisse, 9 (409) pp. 2270-2, 2274.
 
Evaluation of organ-specific peripheral doses after 2-dimensional, 3-dimensional and hybrid intensity modulated radiation therapy for breast cancer based on Monte Carlo and convolution/superposition algorithms: implications for secondary cancer risk assessment.
Joosten A., Matzinger O., Jeanneret-Sozzi W., Bochud F., Moeckli R., 2013/01. Radiotherapy and oncology, 106 (1) pp. 33-41. Peer-reviewed.
 
Immunothérapie: une nouvelle arme contre le cancer de la prostate [Immunotherapy: a therapeutic revolution against prostate cancer?].
Pracht M., Herrera F., Tawadros T., Berthold D., 2013. Revue Médicale Suisse, 9 (387) pp. 1070-1075.
 
Low- and high-grade esthesioneuroblastomas display a distinct natural history and outcome.
Malouf G.G., Casiraghi O., Deutsch E., Guigay J., Temam S., Bourhis J., 2013. European Journal of Cancer, 49 (6) pp. 1324-1334.
 
Phase I trial of oral etoposide in combination with radiotherapy in head and neck squamous cell carcinoma - GORTEC 2004-02.
Tao Y., Bardet E., Rosine D., Rolland F., Bompas E., Daly-Schveitzer N., Lusinchi A., Bourhis J., 2013. Radiation Oncology, 8 p. 40.
Prognostic factors in adult soft tissue sarcoma treated with surgery combined with radiotherapy: a retrospective single-center study on 164 patients.
Cai L., Mirimanoff R.O., Mouhsine E., Guillou L., Leyvraz P.F., Leyvraz S., Gay B., Matzinger O., Ozsahin M., Zouhair A., 2013. Rare Tumors, 5 (4) pp. e55. Peer-reviewed.
 
Radiosensibilité individuelle : les tests vont changer nos pratiques [Intrinsic radiosensitivity: predictive assays that will change the daily practice].
Lacombe J., Riou O., Solassol J., Mangé A., Bourgier C., Fenoglietto P., Pèlegrin A., Ozsahin M., Azria D., 2013. Cancer Radiothérapie, 17 (5-6) pp. 337-343.
 
Radiotherapy options after breast-conserving surgery: how can selection of patients be refined?
Tsoutsou P.G., Jeanneret Sozzi W., Ozsahin M., Delaloye J.F., Bourhis J., 2013. Journal of Clinical Oncology, 31 (36) pp. 4570-4571. Peer-reviewed.
Retrospective feasibility study of simultaneous integrated boost in cervical cancer using Tomotherapy: the impact of organ motion and tumor regression.
Herrera F.G., Callaway S., Delikgoz-Soykut E., Coskun M., Porta L., Meuwly J.Y., Soares-Rodrigues J., Heym L., Moeckli R., Ozsahin M., 2013. Radiation Oncology, 8 (5) pp. 1-10.
 
Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group.
Blanchard P., Bourhis J., Lacas B., Posner M.R., Vermorken J.B., Hernandez J.J., Bourredjem A., Calais G., Paccagnella A., Hitt R. et al., 2013. Journal of Clinical Oncology, 31 (23) pp. 2854-2860.
The role of PET/CT in cervical cancer.
Herrera F.G., Prior J.O., 2013. Frontiers in Oncology, 3 p. 34.
The use of PET/CT in radiotherapy planning: contribution of deformable registration.
Delikgoz Soykut E., Ozsahin E.M., Yukselen Guney Y., Aytac Arslan S., Derinalp Or O., Altundag M.B., Ugurluer G., Tsoutsou P.G., 2013. Frontiers In Oncology, 3 p. 33. Peer-reviewed.
 
Absent benefit of accelerated concomitant chemoradiotherapy.
Prestwich R.J., Sen M., 2012/04. The Lancet. Oncology, 13 (4) pp. e136; author reply e136-7. Peer-reviewed.
 
Assessment of the novel tubulin-binding agent EHT 6706 in combination with ionizing radiation or chemotherapy.
Clémenson C., Chargari C., Désiré L., Casagrande A.S., Bourhis J., Deutsch E., 2012. Investigational New Drugs, 30 (6) pp. 2173-2186. Peer-reviewed.
 
Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial.
Bourhis J., Sire C., Graff P., Grégoire V., Maingon P., Calais G., Gery B., Martin L., Alfonsi M., Desprez P. et al., 2012. Lancet Oncology, 13 (2) pp. 145-153. Peer-reviewed.
 
Definitive organ-sparing treatment of anal canal cancer: can we afford to question it?
Ozsahin M., Santa Cruz O., Bouchaab H., Matzinger O., Tsoutsou P.G., 2012. Journal of Clinical Oncology, 30 (6) pp. 673-675.
 
Definitive radiotherapy for squamous cell carcinoma of the pyriform sinus.
Blanchard P., Tao Y., Veresezan O., Lusinchi A., Le Ridant A.M., Janot F., Daly-Schveitzer N., Bourhis J., 2012. Radiotherapy and Oncology, 105 (2) pp. 232-237. Peer-reviewed.
 
ESTRO 2012 strategy meeting: vision for radiation oncology.
Valentini V., Bourhis J., Hollywood D., 2012. Radiotherapy and Oncology, 103 (1) pp. 99-102. Peer-reviewed.
 
Heterogeneous telomere defects in patients with severe forms of dyskeratosis congenita.
Touzot F., Gaillard L., Vasquez N., Le Guen T., Bertrand Y., Bourhis J., Leblanc T., Fischer A., Soulier J., de Villartay J.P. et al., 2012. Journal of Allergy and Clinical Immunology, 129 (2) pp. 473-82, 482.e1-3. Peer-reviewed.
 
Nanoscale radiotherapy with hafnium oxide nanoparticles.
Maggiorella L., Barouch G., Devaux C., Pottier A., Deutsch E., Bourhis J., Borghi E., Levy L., 2012. Future Oncology, 8 (9) pp. 1167-1181. Peer-reviewed.
 
Retreatment of recurrent head and neck cancer in a previously irradiated field.
Wong S.J., Bourhis J., Langer C.J., 2012. Seminars in Radiation Oncology, 22 (3) pp. 214-219. Peer-reviewed.
The Rare Cancer Network: achievements from 1993 to 2012.
Patel A., Ozsahin M., Mirimanoff R.O., Bhatia S., Chang K., Miller R.C., 2012. Rare Tumors, 4 (3) pp. e35.
 
Modulation pharmacologique des effets tardifs de l'irradiation [Pharmacological modulation of late radio-induced side effects]
Bourgier C., Monceau V., Bourhis J., Deutsch E., Vozenin M.C., 2011/08. Cancer radiotherapie, 15 (5) pp. 383-389. Peer-reviewed.
 
A new method of assessing the dose-carcinogenic effect relationship in patients exposed to ionizing radiation. A concise presentation of preliminary data.
Tubiana M., Diallo I., Chavaudra J., Lefkopoulos D., Bourhis J., Girinsky T., Brider A., Hawkins M., Haddy N., El-Fayech C. et al., 2011. Health Physics, 100 (3) pp. 296-299. Peer-reviewed.
 
A phase I trial combining oral cisplatin (CP Ethypharm) with radiotherapy in patients with locally advanced head and neck squamous cell carcinoma.
Tao Y., Rezaï K., Brain E., Etessami A., Lusinchi A., Temam S., Urien S., Van M.L., Vauzelle-Kervroedan F., Lokiec F. et al., 2011. Radiotherapy and Oncology, 98 (1) pp. 42-47. Peer-reviewed.
 
Accelerated radiotherapy and concomitant high dose chemotherapy in non resectable stage IV locally advanced HNSCC: results of a GORTEC randomized trial.
Bourhis J., Lapeyre M., Tortochaux J., Lusinchi A., Etessami A., Ducourtieux M., Geoffrois L., Domenge C., Verrelle P., Wibault P. et al., 2011. Radiotherapy and Oncology, 100 (1) pp. 56-61.
 
Chromosomal minimal critical regions in therapy-related leukemia appear different from those of de novo leukemia by high-resolution aCGH.
Itzhar N., Dessen P., Toujani S., Auger N., Preudhomme C., Richon C., Lazar V., Saada V., Bennaceur A., Bourhis J.H. et al., 2011. Plos One, 6 (2) pp. e16623. Peer-reviewed.
 
Early side effects of three-dimensional conformal external beam accelerated partial breast irradiation to a total dose of 40 Gy in one week (a phase II trial).
Bourgier C., Pichenot C., Verstraet R., El Nemr M., Heymann S., Biron B., Delaloge S., Mathieu M.C., Garbay J.R., Bourhis J. et al., 2011. International Journal of Radiation Oncology, Biology, Physics, 81 (5) pp. 1228-1235. Peer-reviewed.
 
Effect of amifostine on survival among patients treated with radiotherapy: a meta-analysis of individual patient data.
Bourhis J., Blanchard P., Maillard E., Brizel D.M., Movsas B., Buentzel J., Langendijk J.A., Komaki R., Swan Leong S., Levendag P. et al., 2011. Journal of Clinical Oncology, 29 (18) pp. 2590-2597. Peer-reviewed.
 
IMRT or conformal radiotherapy for adjuvant treatment of retroperitoneal sarcoma?
Paumier A., Le Péchoux C., Beaudré A., Negretti L., Ferreira I., Roberti E., Brahim J., Lefkopoulos D., Daly-Schweitzer N., Bourhis J. et al., 2011. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology, 99 (1) pp. 73-78. Peer-reviewed.
 
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site.
Blanchard P., Baujat B., Holostenco V., Bourredjem A., Baey C., Bourhis J., Pignon J.P., MACH-CH Collaborative group, 2011. Radiotherapy and Oncology, 100 (1) pp. 33-40. Peer-reviewed.
 
Mixed treatment comparison meta-analysis of altered fractionated radiotherapy and chemotherapy in head and neck cancer.
Blanchard P., Hill C., Guihenneuc-Jouyaux C., Baey C., Bourhis J., Pignon J.P., MACH-NC , MARCH Collaborative Groups, 2011. Journal of Clinical Epidemiology, 64 (9) pp. 985-992.
 
New techniques in radiation therapy for head and neck cancer: IMRT, CyberKnife, protons, and carbon ions. Improved effectiveness and safety? Impact on survival?
Thariat J., Bolle S., Demizu Y., Marcy P.Y., Hu Y., Santini J., Bourhis J., Pommier P., 2011. Anti-cancer Drugs, 22 (7) pp. 596-606. Peer-reviewed.
 
Preclinical assessment of JNJ-26854165 (Serdemetan), a novel tryptamine compound with radiosensitizing activity in vitro and in tumor xenografts.
Chargari C., Leteur C., Angevin E., Bashir T., Schoentjes B., Arts J., Janicot M., Bourhis J., Deutsch E., 2011. Cancer Letters, 312 (2) pp. 209-218. Peer-reviewed.
 
Randomized phase III trial (GORTEC 98-03) comparing re-irradiation plus chemotherapy versus methotrexate in patients with recurrent or a second primary head and neck squamous cell carcinoma, treated with a palliative intent.
Tortochaux J., Tao Y., Tournay E., Lapeyre M., Lesaunier F., Bardet E., Janot F., Lusinchi A., Benhamou E., Bontemps P. et al., 2011. Radiotherapy and Oncology, 100 (1) pp. 70-75. Peer-reviewed.
 
Subcutaneous compared with intravenous administration of amifostine in patients with head and neck cancer receiving radiotherapy: final results of the GORTEC2000-02 phase III randomized trial.
Bardet E., Martin L., Calais G., Alfonsi M., Feham N.E., Tuchais C., Boisselier P., Dessard-Diana B., Seng S.H., Garaud P. et al., 2011. Journal of Clinical Oncology, 29 (2) pp. 127-133. Peer-reviewed.
 
Microvascular leakage and contrast enhancement as prognostic factors for recurrence in unfavorable low-grade gliomas.
Dhermain F., Saliou G., Parker F., Page P., Hoang-Xuan K., Lacroix C., Tournay E., Bourhis J., Ducreux D., 2010/03. Journal of neuro-oncology, 97 (1) pp. 81-88. Peer-reviewed.
 
Advances in radiotherapy of head and neck cancers.
Tao Y., Daly-Schveitzer N., Lusinchi A., Bourhis J., 2010. Current Opinion In Oncology, 22 (3) pp. 194-199. Peer-reviewed.
 
Cetuximab in the management of locoregionally advanced head and neck cancer: expanding the treatment options?
Bourhis J., Lefebvre J.L., Vermorken J.B., 2010. European Journal of Cancer, 46 (11) pp. 1979-1989. Peer-reviewed.
 
Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02.
Peters L.J., O'Sullivan B., Giralt J., Fitzgerald T.J., Trotti A., Bernier J., Bourhis J., Yuen K., Fisher R., Rischin D., 2010. Journal of Clinical Oncology, 28 (18) pp. 2996-3001. Peer-reviewed.
 
Inhibition of BCL-2 in small cell lung cancer cell lines with oblimersen, an antisense BCL-2 oligodeoxynucleotide (ODN): in vitro and in vivo enhancement of radiation response.
Loriot Y., Mordant P., Brown B.D., Bourhis J., Soria J.C., Deutsch E., 2010. Anticancer Research, 30 (10) pp. 3869-3878. Peer-reviewed.
 
Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer.
Tukenova M., Guibout C., Oberlin O., Doyon F., Mousannif A., Haddy N., Guérin S., Pacquement H., Aouba A., Hawkins M. et al., 2010. Journal of Clinical Oncology, 28 (8) pp. 1308-1315. Peer-reviewed.
 
Salvage surgery after concomitant chemoradiation in head and neck squamous cell carcinomas - stratification for postsalvage survival.
Tan H.K., Giger R., Auperin A., Bourhis J., Janot F., Temam S., 2010. Head and Neck, 32 (2) pp. 139-147. Peer-reviewed.
 
Tirapazamine, cisplatin, and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck (TROG 02.02, HeadSTART): a phase III trial of the Trans-Tasman Radiation Oncology Group.
Rischin D., Peters L.J., O'Sullivan B., Giralt J., Fisher R., Yuen K., Trotti A., Bernier J., Bourhis J., Ringash J. et al., 2010. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 28 (18) pp. 2989-2995. Peer-reviewed.
 
What have we learned from human papillomavirus-positive tumors? Trying to connect data about biomarkers among human papillomavirus-related squamous cell carcinomas.
Vozenin M.C., Bourhis J., Deutsch E., 2010. Journal of Clinical Oncology, 28 (20) pp. e340-1; author reply e342. Peer-reviewed.
 
A pre-clinical assessment of an atlas-based automatic segmentation tool for the head and neck.
Sims R., Isambert A., Grégoire V., Bidault F., Fresco L., Sage J., Mills J., Bourhis J., Lefkopoulos D., Commowick O. et al., 2009. Radiotherapy and Oncology, 93 (3) pp. 474-478. Peer-reviewed.
 
Current concepts of management in radiotherapy for head and neck squamous-cell cancer.
Mazeron R., Tao Y., Lusinchi A., Bourhis J., 2009. Oral Oncology, 45 (4-5) pp. 402-408. Peer-reviewed.
 
Differential effect triggered by a heparan mimetic of the RGTA family preventing oral mucositis without tumor protection.
Mangoni M., Yue X., Morin C., Violot D., Frascogna V., Tao Y., Opolon P., Castaing M., Auperin A., Biti G. et al., 2009. International Journal of Radiation Oncology, Biology, Physics, 74 (4) pp. 1242-1250. Peer-reviewed.
 
Interfractional set-up errors evaluation by daily electronic portal imaging of IMRT in head and neck cancer patients.
Pehlivan B., Pichenot C., Castaing M., Auperin A., Lefkopoulos D., Arriagada R., Bourhis J., 2009. Acta Oncologica, 48 (3) pp. 440-445. Peer-reviewed.
 
Larynx preservation clinical trial design: key issues and recommendations--a consensus panel summary.
Lefebvre J.L., Ang K.K., Larynx Preservation Consensus Panel, 2009. Head and Neck, 31 (4) pp. 429-441. Peer-reviewed.
 
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients.
Pignon J.P., le Maître A., Maillard E., Bourhis J., MACH-NC Collaborative Group, 2009. Radiotherapy and Oncology, 92 (1) pp. 4-14. Peer-reviewed.
 
Novel anti-metastatic action of cidofovir mediated by inhibition of E6/E7, CXCR4 and Rho/ROCK signaling in HPV tumor cells.
Amine A., Rivera S., Opolon P., Dekkal M., Biard D.S., Bouamar H., Louache F., McKay M.J., Bourhis J., Deutsch E. et al., 2009. Plos One, 4 (3) pp. e5018. Peer-reviewed.
 
Oral cavity squamous cell carcinoma in 260 patients aged 80years or more.
Ortholan C., Lusinchi A., Italiano A., Bensadoun R.J., Auperin A., Poissonnet G., Bozec A., Arriagada R., Temam S., Benezery K. et al., 2009. Radiotherapy and Oncology, 93 (3) pp. 516-523. Peer-reviewed.
 
Phase I study of lapatinib in combination with chemoradiation in patients with locally advanced squamous cell carcinoma of the head and neck.
Harrington K.J., El-Hariry I.A., Holford C.S., Lusinchi A., Nutting C.M., Rosine D., Tanay M., Deutsch E., Matthews J., D'Ambrosio C. et al., 2009. Journal of Clinical Oncology, 27 (7) pp. 1100-1107. Peer-reviewed.
 
Radiosensitization by Chir-124, a selective CHK1 inhibitor: effects of p53 and cell cycle checkpoints.
Tao Y., Leteur C., Yang C., Zhang P., Castedo M., Pierré A., Golsteyn R.M., Bourhis J., Kroemer G., Deutsch E., 2009. Cell Cycle, 8 (8) pp. 1196-1205. Peer-reviewed.
 
Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data.
Michiels S., Le Maître A., Buyse M., Burzykowski T., Maillard E., Bogaerts J., Vermorken J.B., Budach W., Pajak T.F., Ang K.K. et al., 2009. Lancet. Oncology, 10 (4) pp. 341-350. Peer-reviewed.
 
The aurora B kinase inhibitor AZD1152 sensitizes cancer cells to fractionated irradiation and induces mitotic catastrophe.
Tao Y., Leteur C., Calderaro J., Girdler F., Zhang P., Frascogna V., Varna M., Opolon P., Castedo M., Bourhis J. et al., 2009. Cell Cycle, 8 (19) pp. 3172-3181. Peer-reviewed.
 
Botulinum toxin for radiation-induced facial pain and trismus.
Hartl D.M., Cohen M., Juliéron M., Marandas P., Janot F., Bourhis J., 2008. Otolaryngology--head and Neck Surgery, 138 (4) pp. 459-463. Peer-reviewed.
 
Comparison of dose contribution to normal pelvic tissues among conventional, conformal and intensity-modulated radiotherapy techniques in prostate cancer.
Tao Y., Lefkopoulos D., Ibrahima D., Bridier A., Polizzi Mdel P, Wibault P., De Crevoisier R., Arriagada R., Bourhis J., 2008. Acta Oncologica, 47 (3) pp. 442-450. Peer-reviewed.
 
Distant metastasis of undifferentiated carcinoma of nasopharyngeal type.
Tao Y., Bidault F., Bosq J., Bourhis J., 2008. Onkologie, 31 (11) pp. 574-575. Peer-reviewed.
 
Molecular profiling of uterine cervix carcinoma: an overview with a special focus on rationally designed target-based anticancer agents.
Magné N., Chargari C., Deutsch E., Castadot P., Ghalibafian M., Bourhis J., Haie-Meder C., 2008. Cancer Metastasis Reviews, 27 (4) pp. 737-750. Peer-reviewed.
 
Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma.
Janot F., de Raucourt D., Benhamou E., Ferron C., Dolivet G., Bensadoun R.J., Hamoir M., Géry B., Julieron M., Castaing M. et al., 2008. Journal of Clinical Oncology, 26 (34) pp. 5518-5523. Peer-reviewed.
 
Targeted therapies in head and neck cancer: past, present and future.
Rapidis A.D., Vermorken J.B., Bourhis J., 2008. Reviews on Recent Clinical Trials, 3 (3) pp. 156-166.
 
The efficacy and toxicity of EGFR in the settings of radiotherapy: focus on published clinical trials.
Magné N., Chargari C., Castadot P., Ghalibafian M., Soria J.C., Haie-Meder C., Bourhis J., Deutsch E., 2008. European Journal of Cancer, 44 (15) pp. 2133-2143. Peer-reviewed.
 
Glucagon-like peptide-2 improves both acute and late experimental radiation enteritis in the rat.
Torres S., Thim L., Milliat F., Vozenin-Brotons M.C., Olsen U.B., Ahnfelt-Rønne I., Bourhis J., Benderitter M., François A., 2007. International Journal of Radiation Oncology, Biology, Physics, 69 (5) pp. 1563-1571.
 
Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy.
Graff P., Lapeyre M., Desandes E., Ortholan C., Bensadoun R.J., Alfonsi M., Maingon P., Giraud P., Bourhis J., Marchesi V. et al., 2007. International Journal of Radiation Oncology, Biology, Physics, 67 (5) pp. 1309-1317. Peer-reviewed.
 
Implications of learning effects for hospital costs of new health technologies: the case of intensity modulated radiation therapy.
Bonastre J., Noël E., Chevalier J., Gerard J.P., Lefkopoulos D., Bourhis J., Bensadoun R.J., de Pouvourville G., STIC IMRT 2002 Investigators, 2007. International Journal of Technology Assessment In Health Care, 23 (2) pp. 248-254.
 
Individual patients' data meta-analyses in head and neck cancer.
Bourhis J., Le Maître A., Baujat B., Audry H., Pignon J.P., Meta-Analysis of Chemotherapy in Head Neck Cancer Collaborative Group, Meta-Analysis of Radiotherapy in Carcinoma of Head Neck Collaborative Group, Meta-Analysis of Chemotherapy in Nasopharynx Carcinoma Collaborative Group, 2007. Current Opinion in Oncology, 19 (3) pp. 188-194. Peer-reviewed.
 
Mechanisms of disease: signaling of the insulin-like growth factor 1 receptor pathway--therapeutic perspectives in cancer.
Tao Y., Pinzi V., Bourhis J., Deutsch E., 2007. Nature Clinical Practice. Oncology, 4 (10) pp. 591-602. Peer-reviewed.
 
Meta-Analyses of Chemotherapy in Head and Neck Cancer (MACH-NC): an update.
Pignon J.P., le Maître A., Bourhis J., MACH-NC Collaborative Group, 2007. International Journal of Radiation Oncology, Biology, Physics, 69 (2 Suppl) pp. S112-S114. Peer-reviewed.
 
Phase I trial of tirapazamine, cisplatin, and concurrent accelerated boost reirradiation in patients with recurrent head and neck cancer.
Cohen E.E., Rosine D., Haraf D.J., Loh E., Shen L., Lusinchi A., Vokes E.E., Bourhis J., 2007. International Journal of Radiation Oncology, Biology, Physics, 67 (3) pp. 678-684. Peer-reviewed.
 
Pravastatin Inhibits the Rho/CCN2/extracellular matrix cascade in human fibrosis explants and improves radiation-induced intestinal fibrosis in rats.
Haydont V., Bourgier C., Pocard M., Lusinchi A., Aigueperse J., Mathé D., Bourhis J., Vozenin-Brotons M.C., 2007. Clinical Cancer Research, 13 (18 Pt 1) pp. 5331-5340. Peer-reviewed.
 
Reirradiation in squamous cell head and neck cancer: recent developments and future directions.
Langendijk J.A., Bourhis J., 2007. Current Opinion in Oncology, 19 (3) pp. 202-209. Peer-reviewed.
 
Successful mitigation of delayed intestinal radiation injury using pravastatin is not associated with acute injury improvement or tumor protection.
Haydont V., Gilliot O., Rivera S., Bourgier C., François A., Aigueperse J., Bourhis J., Vozenin-Brotons M.C., 2007. International Journal of Radiation Oncology, Biology, Physics, 68 (5) pp. 1471-1482. Peer-reviewed.
 
Telomere shortening and associated chromosomal instability in peripheral blood lymphocytes of patients with Hodgkin's lymphoma prior to any treatment are predictive of second cancers.
M'kacher R., Bennaceur-Griscelli A., Girinsky T., Koscielny S., Delhommeau F., Dossou J., Violot D., Leclercq E., Courtier M.H., Béron-Gaillard N. et al., 2007. International Journal of Radiation Oncology, Biology, Physics, 68 (2) pp. 465-471. Peer-reviewed.
 
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy.
Apetoh L., Ghiringhelli F., Tesniere A., Obeid M., Ortiz C., Criollo A., Mignot G., Maiuri M.C., Ullrich E., Saulnier P. et al., 2007. Nature Medicine, 13 (9) pp. 1050-1059. Peer-reviewed.
 
Caspase independence of radio-induced cell death.
Zhang P., Castedo M., Tao Y., Violot D., Métivier D., Deutsch E., Kroemer G., Bourhis J., 2006. Oncogene, 25 (59) pp. 7758-7770.
 
Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients.
Baujat B., Audry H., Bourhis J., Chan A.T., Onat H., Chua D.T., Kwong D.L., Al-Sarraf M., Chi K.H., Hareyama M. et al., 2006. International Journal of Radiation Oncology, Biology, Physics, 64 (1) pp. 47-56. Peer-reviewed.
 
Cidofovir administered with radiation displays an antiangiogenic effect mediated by E6 inhibition and subsequent TP53-dependent VEGF repression in HPV18+ cell lines.
Amine A., Vozenin-Brotons M.C., Abdulkarim B., Violot D., Aubel C., Bourhis J., 2006. Radiation Research, 166 (4) pp. 600-610. Peer-reviewed.
 
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.
Bourhis J., Overgaard J., Audry H., Ang K.K., Saunders M., Bernier J., Horiot J.C., Le Maître A., Pajak T.F., Poulsen M.G. et al., 2006. Lancet, 368 (9538) pp. 843-854. Peer-reviewed.
 
Hypoxia response pathways and radiotherapy for head and neck cancer.
Bourhis J., 2006. Journal of Clinical Oncology, 24 (5) pp. 725-726. Peer-reviewed.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Fax. +41 21 692 26 15
Swiss University